Tango Therapeutics, Inc. SEC filings TNGX
Tango Therapeutics, Inc. has 424 filings in SEC EDGAR's recent list, going back to Jul 30, 2020. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 11, 2026 | Aug 11, 2026 |
| 424B5 | Prospectus supplement | Aug 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change, Regulation FD disclosure
|
Aug 7, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 6, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 3 | Initial insider ownership | Jun 23, 2026 | Jun 19, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2026 | Jun 19, 2026 |
| 144 | Notice of proposed sale | Jun 17, 2026 | — |
| 144 | Notice of proposed sale | Jun 11, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jun 10, 2026 | Jun 9, 2026 |
| 424B5 | Prospectus supplement | Jun 10, 2026 | — |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| FWP | Free writing prospectus | Jun 10, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 424B5 | Prospectus supplement | Jun 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 8, 2026 | May 7, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 4, 2026 | — |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 15, 2026 |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 15, 2026 |
| ARS | Annual report to shareholders | Apr 17, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 15, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 144 | Notice of proposed sale | Mar 25, 2026 | — |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 10, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 6, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 30, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 3 | Initial insider ownership | Jan 6, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Jan 2, 2026 |
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 21, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 21, 2025 | Nov 18, 2025 |
| S-3ASR | Automatic shelf registration | Nov 21, 2025 | — |
| S-3 | Shelf registration | Nov 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 4 | Insider transaction | Nov 4, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| D | Filing | Oct 28, 2025 | — |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 24, 2025 | Oct 23, 2025 |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 144 | Notice of proposed sale | Oct 23, 2025 | — |
| FWP | Free writing prospectus | Oct 23, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Sep 29, 2025 | Sep 25, 2025 |
| 144 | Notice of proposed sale | Sep 25, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 22, 2025 | — |
| 4 | Insider transaction | Sep 17, 2025 | Sep 16, 2025 |
| 144 | Notice of proposed sale | Sep 17, 2025 | — |
| 4 | Insider transaction | Sep 9, 2025 | Sep 5, 2025 |
| 144 | Notice of proposed sale | Sep 8, 2025 | — |
| 144 | Notice of proposed sale | Sep 5, 2025 | — |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2025 | Aug 21, 2025 |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 4 | Insider transaction | Aug 21, 2025 | Aug 19, 2025 |
| 144 | Notice of proposed sale | Aug 19, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 13, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| EFFECT | Filing | May 21, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| CORRESP | Letter to the SEC | May 19, 2025 | — |
| S-3 | Shelf registration | May 12, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| DEFR14A | Filing | Apr 24, 2025 | — |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 21, 2025 | Apr 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Apr 11, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Aug 10, 2022 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 2, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 20, 2024 | — |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 6, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 7, 2024 | — |
| 4 | Insider transaction | Nov 7, 2024 | Nov 6, 2024 |
| 144 | Notice of proposed sale | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2024 | Nov 6, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 28, 2024 | — |
| 4 | Insider transaction | Oct 28, 2024 | Oct 25, 2024 |
| 144 | Notice of proposed sale | Oct 25, 2024 | — |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 144 | Notice of proposed sale | Oct 22, 2024 | — |
| 3 | Initial insider ownership | Oct 22, 2024 | Oct 10, 2024 |
| 144 | Notice of proposed sale | Oct 22, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 15, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 15, 2024 | — |
| 4 | Insider transaction | Sep 17, 2024 | Sep 13, 2024 |
| 144 | Notice of proposed sale | Sep 13, 2024 | — |
| 4 | Insider transaction | Sep 9, 2024 | Sep 5, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 144 | Notice of proposed sale | Sep 5, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 4, 2024 | — |
| 4 | Insider transaction | Sep 4, 2024 | Aug 30, 2024 |
| 144 | Notice of proposed sale | Aug 30, 2024 | — |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 144 | Notice of proposed sale | Aug 27, 2024 | — |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 144 | Notice of proposed sale | Aug 19, 2024 | — |
| 144 | Notice of proposed sale | Aug 16, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 30, 2024 |
| 144 | Notice of proposed sale | Aug 1, 2024 | — |
| 144 | Notice of proposed sale | Jul 31, 2024 | — |
| 144 | Notice of proposed sale | Jul 30, 2024 | — |
| 4 | Insider transaction | Jul 30, 2024 | Jul 26, 2024 |
| 144 | Notice of proposed sale | Jul 26, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TNGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1819133
- Former names
- BCTG Acquisition Corp. (until Aug 9, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.